Skip to main content
Chemcrux Enterprises Limited logo

Chemcrux Enterprises Limited — Investor Relations & Filings

Ticker · 540395 ISIN · INE298W01016 LEI · 3358004EQSSC7GGSG568 BSE.NS Manufacturing
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS 540395

About Chemcrux Enterprises Limited

https://www.chemcrux.com/

Chemcrux Enterprises Limited specializes in the manufacturing of bulk drug intermediates and specialty chemicals. The company focuses on complex chemical processes, including high-pressure oxidation, chlorination, and nitration. Its product portfolio primarily serves the pharmaceutical and pigment sectors. Chemcrux operates manufacturing facilities equipped for diverse chemical reactions and maintains quality standards through ISO 9001:2015 and ISO 14001:2015 certifications. Key products include intermediates used in the synthesis of various active pharmaceutical ingredients and high-performance pigments. The company emphasizes process optimization and research and development to deliver high-purity chemical solutions while ensuring environmental compliance.

Recent filings

Filing Released Lang Actions
Annual Secretarial Compliance Report for the year ended 31st March 2026
Regulatory Filings Classification · 92% confidence The document is an Annual Secretarial Compliance Report issued by a Practising Company Secretary under SEBI LODR Regulation 24A, submitted to the stock exchange. It is essentially an attestation/certification of statutory compliance, not the actual annual report or financial statements. Under the Certification Rule, such officer certifications and compliance certificates should be classified as a general regulatory filing. Therefore, the correct category is Regulatory Filings (RNS).
2026-05-25 English
Newspaper Publication of Standalone and Consolidated Audited Financial Results for the quarter and year ended 31st March 2026.
Report Publication Announcement Classification · 78% confidence The document is a cover letter to BSE notifying the exchange of a newspaper publication of the company’s standalone and consolidated audited financial results for the quarter and year ended 31 March 2026, pursuant to SEBI LODR regulations. It does not itself contain a full financial report or substantive analysis—it merely announces that the audited results have been published in newspapers and directs readers to the attachments or website. Under the “Menu vs Meal” rule, this is an announcement of publication rather than the report itself, matching the definition of Report Publication Announcement (RPA).
2026-05-15 English
The NRC has granted 107700 stock options to eligible employees pursuant to ESOP 2025/ Scheme. The grant date for ESOP Grant 1 - 2026 will be 15th May 2026.
Share Issue/Capital Change Classification · 85% confidence The document is an intimation under Regulation 30 of SEBI LODR detailing the grant of 107,700 stock options under the company’s ESOP Scheme, which will involve a new issue of equity shares upon exercise. This constitutes a capital change announcement rather than a financial report, proxy, or dividend notice. The appropriate category for announcing a new share issuance/stock option grant is Share Issue/Capital Change (SHA).
2026-05-14 English
Kalichem Private Limited (WOS) as part of its proposed diversification into inorganic chemical sector has filed CTE Amendment to GPCB for addition of various inorganic chemicals.
Regulatory Filings Classification · 87% confidence The document is a disclosure letter addressed to BSE under Regulation 30 of SEBI (LODR) Regulations, 2015, informing the exchange of a material event (application for environmental consent amendment) by the listed company’s subsidiary. It is a mandatory stock exchange filing/disclosure rather than a financial report, management discussion, or other specific category. This fits the ‘Regulatory Filings’ (RNS) fallback category for miscellaneous compliance announcements.
2026-05-14 English
The Board at their meeting held today (14.05.2026) approved to incorporate a non-profit making company u/s 8 of the Companies Act, 2013 as the Wholly owned subsidiary of the Company; subject ....
Regulatory Filings Classification · 84% confidence The document is an outcome-of-board-meeting notice submitted to the stock exchange under Regulation 30 of SEBI LODR. It does not contain actual financial statements or detailed numbers (just a statement that the audited results were approved), nor is it a standalone report, call transcript, proxy, or notice of dividend payment. It is a general regulatory announcement/disclosure with information on board resolutions. Therefore, it falls into the fallback category "Regulatory Filings (RNS)."
2026-05-14 English
Recommendation of Final Dividend at rate of 10% (Re. 1/- per share) on the equity share of Rs. 10/- each subject to approval of members at ensuing AGM
Regulatory Filings Classification · 85% confidence The document is an announcement under SEBI LODR Regulation 30 regarding the outcome of a Board Meeting, notifying the stock exchange of approved financial results, dividend recommendation and subsidiary incorporation. It does not itself contain detailed financial statements, management changes, or attach a report, nor is it reporting actual quarterly financial data. It is a general regulatory disclosure/fallback announcement. Therefore it is classified as a Regulatory Filing (RNS).
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.